| Year |
Citation |
Score |
| 2015 |
Dougherty DM, Karns TE, Mullen J, Liang Y, Lake SL, Roache JD, Hill-Kapturczak N. Corrigendum to "Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking" [Drug and Alcohol Dependence, 148, (2015), 77-84 doi: 10.1016/j.drugalcdep.2014.12.021] Drug and Alcohol Dependence. 149: 304. DOI: 10.1016/J.Drugalcdep.2015.01.037 |
0.315 |
|
| 2009 |
Anderson AL, Reid MS, Li SH, Holmes T, Shemanski L, Slee A, Smith EV, Kahn R, Chiang N, Vocci F, Ciraulo D, Dackis C, Roache JD, Salloum IM, Somoza E, et al. Modafinil for the treatment of cocaine dependence. Drug and Alcohol Dependence. 104: 133-9. PMID 19560290 DOI: 10.1016/J.Drugalcdep.2009.04.015 |
0.315 |
|
| 2008 |
Roache JD, Wang Y, Ait-Daoud N, Johnson BA. Prediction of serotonergic treatment efficacy using age of onset and Type A/B typologies of alcoholism. Alcoholism, Clinical and Experimental Research. 32: 1502-12. PMID 18565156 DOI: 10.1111/J.1530-0277.2008.00717.X |
0.344 |
|
| 2008 |
Murff W, Roache JD. SAFETY OF DEXTROAMPHETAMINE AND COCAINE COMBINATIONS IN COCAINE USERS Alcoholism: Clinical and Experimental Research. 32: 371A-371A. DOI: 10.1111/J.1530-0277.2008.00689_19.X |
0.346 |
|
| 2008 |
Ginsburg BC, Gerak LR, McMahon LR, Roache JD. Neurosteroids in alcohol and substance use Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders: Novel Strategies For Research and Treatment. 509-538. DOI: 10.1007/978-1-4020-6854-6_25 |
0.311 |
|
| 2007 |
Carter LP, Griffiths RR, Suess PE, Casada JH, Wallace CL, Roache JD. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects. The Journal of Pharmacology and Experimental Therapeutics. 322: 749-59. PMID 17502431 DOI: 10.1124/Jpet.107.119693 |
0.41 |
|
| 2007 |
Johnson BA, Wells LT, Roache JD, Wallace CL, Ait-Daoud N, Dawes MA, Liu L, Wang XQ, Javors MA. Kinetic and cardiovascular effects of acute topiramate dosing among non-treatment-seeking, methamphetamine-dependent individuals. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 31: 455-61. PMID 17184890 DOI: 10.1016/J.Pnpbp.2006.11.011 |
0.396 |
|
| 2007 |
Johnson BA, Roache JD, Ait-Daoud N, Wells LT, Wallace CL, Dawes MA, Liu L, Wang XQ. Effects of topiramate on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition in recently abstinent methamphetamine-dependent individuals. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 31: 123-30. PMID 16978753 DOI: 10.1016/J.Pnpbp.2006.08.002 |
0.339 |
|
| 2007 |
Johnson BA, Roache JD, Ait-Daoud N, Wells LT, Wallace CL, Dawes MA, Liu L, Wang XQ. Effects of acute topiramate dosing on methamphetamine-induced subjective mood. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 85-98. PMID 16448579 DOI: 10.1017/S1461145705006401 |
0.441 |
|
| 2006 |
Johnson BA, Roache JD, Ait-Daoud N, Javors MA, Harrison JM, Elkashef A, Mojsiak J, Li SH, Bloch DA. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence. Drug and Alcohol Dependence. 84: 256-63. PMID 16631323 DOI: 10.1016/J.Drugalcdep.2006.02.011 |
0.376 |
|
| 2006 |
Miller PM, Spies C, Neumann T, Javors MA, Hoyumpa AM, Roache J, Webb A, Kashi M, Sharkey FE, Anton RF, Egan BM, Basile J, Nguyen S, Fleming MF, Dillie KS. Alcohol biomarker screening in medical and surgical settings. Alcoholism, Clinical and Experimental Research. 30: 185-93. PMID 16441267 DOI: 10.1111/J.1530-0277.2006.00029.X |
0.308 |
|
| 2006 |
Newton TF, Roache JD, De La Garza R, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1537-44. PMID 16319910 DOI: 10.1038/Sj.Npp.1300979 |
0.376 |
|
| 2005 |
Roache JD, Johnson BA, Ait-Daoud N, Mauldin JB, Thornton JE, Wells LT, Murff WL. Effects of repeated-dose isradipine on the abuse liability of cocaine. Experimental and Clinical Psychopharmacology. 13: 319-26. PMID 16366762 DOI: 10.1037/1064-1297.13.4.319 |
0.353 |
|
| 2005 |
Johnson BA, Ait-Daoud N, Roache JD. The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field. Journal of Studies On Alcohol. Supplement. 157-67; discussion 1. PMID 16223067 DOI: 10.15288/Jsas.2005.S15.157 |
0.335 |
|
| 2005 |
Newton TF, Roache JD, De La Garza R, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R. Safety of intravenous methamphetamine administration during treatment with bupropion. Psychopharmacology. 182: 426-35. PMID 16163531 DOI: 10.1007/S00213-005-0102-8 |
0.389 |
|
| 2005 |
Johnson BA, Wells LT, Roache JD, Wallace C, Ait-Daoud N, Wang Y. Isradipine decreases the hemodynamic response of cocaine and methamphetamine results from two human laboratory studies: results from two human laboratory studies. American Journal of Hypertension. 18: 813-22. PMID 15925741 DOI: 10.1016/J.Amjhyper.2005.01.020 |
0.336 |
|
| 2005 |
Johnson BA, Roache JD, Ait-Daoud N, Wallace CL, Wells LT, Wang Y, Dawes MA. Effects of isradipine on cocaine-induced changes in cognitive performance in recently abstinent cocaine-dependent individuals. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 8: 549-56. PMID 15916717 DOI: 10.1017/S1461145705005511 |
0.327 |
|
| 2005 |
Johnson BA, Roache JD, Ait-Daoud N, Wallace C, Wells L, Dawes M, Wang Y. Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 8: 203-13. PMID 15850499 DOI: 10.1017/S1461145704005036 |
0.412 |
|
| 2005 |
Wurst FM, Alling C, Aradottir S, Pragst F, Allen JP, Weinmann W, Marmillot P, Ghosh P, Lakshman R, Skipper GE, Neumann T, Spies C, Javors M, Johnson BA, Ait-Daoud N, ... ... Roache JD, et al. Emerging biomarkers: new directions and clinical applications. Alcoholism, Clinical and Experimental Research. 29: 465-73. PMID 15770123 DOI: 10.1097/01.Alc.0000156082.08248.Ab |
0.32 |
|
| 2005 |
Johnson BA, Dawes MA, Roache JD, Wells LT, Ait-Daoud N, Mauldin JB, Wang Y, Lancaster JL, Fox PT. Acute intravenous low- and high-dose cocaine reduces quantitative global and regional cerebral blood flow in recently abstinent subjects with cocaine use disorder. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 25: 928-36. PMID 15758948 DOI: 10.1038/Sj.Jcbfm.9600093 |
0.348 |
|
| 2005 |
Johnson BA, Javors MA, Lam YW, Wells LT, Tiouririne M, Roache JD, Ait-Daoud N, Lawson K. Kinetic and cardiovascular comparison of immediate-release isradipine and sustained-release isradipine among non-treatment-seeking, cocaine-dependent individuals. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 15-20. PMID 15610940 DOI: 10.1016/J.Pnpbp.2004.08.014 |
0.398 |
|
| 2005 |
Johnson BA, Roache JD, Ait-Daoud N, Wallace C, Wells LT, Wang Y. Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition. Psychopharmacology. 178: 296-302. PMID 15452681 DOI: 10.1007/S00213-004-1998-0 |
0.326 |
|
| 2004 |
Johnson BA, Roache JD, Ait-Daoud N, Wells LT, Mauldin JB. Effects of isradipine on cocaine-induced subjective mood. Journal of Clinical Psychopharmacology. 24: 180-91. PMID 15206666 DOI: 10.1097/01.Jcp.0000115662.45074.C3 |
0.363 |
|
| 2004 |
McBride WJ, Lovinger DM, Machu T, Thielen RJ, Rodd ZA, Murphy JM, Roache JD, Johnson BA. Serotonin-3 receptors in the actions of alcohol, alcohol reinforcement, and alcoholism. Alcoholism, Clinical and Experimental Research. 28: 257-67. PMID 15112933 DOI: 10.1097/01.Alc.0000113419.99915.Da |
0.3 |
|
| 2003 |
Johnson BA, O'Malley SS, Ciraulo DA, Roache JD, Chambers RA, Sarid-Segal O, Couper D. Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects. Journal of Clinical Psychopharmacology. 23: 281-93. PMID 12826990 DOI: 10.1097/01.Jcp.0000084029.22282.Bb |
0.402 |
|
| 2003 |
Sloan TB, Roache JD, Johnson BA. The role of anxiety in predicting drinking behaviour. Alcohol and Alcoholism (Oxford, Oxfordshire). 38: 360-3. PMID 12814905 DOI: 10.1093/Alcalc/Agg090 |
0.308 |
|
| 2003 |
Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet. 361: 1677-85. PMID 12767733 DOI: 10.1016/S0140-6736(03)13370-3 |
0.351 |
|
| 2002 |
Gomez TH, Roache JD, Meisch RA. Relative reinforcing effects of different benzodiazepine doses for rhesus monkeys. Drug and Alcohol Dependence. 68: 275-83. PMID 12393222 DOI: 10.1016/S0376-8716(02)00222-3 |
0.355 |
|
| 2002 |
Gomez TH, Roache JD, Meisch RA. Orally delivered alprazolam, diazepam, and triazolam as reinforcers in rhesus monkeys. Psychopharmacology. 161: 86-94. PMID 11967635 DOI: 10.1007/S00213-002-1019-0 |
0.332 |
|
| 2002 |
Johnson BA, Roache JD, Ait-Daoud N, Zanca NA, Velazquez M. Ondansetron reduces the craving of biologically predisposed alcoholics. Psychopharmacology. 160: 408-13. PMID 11919668 DOI: 10.1007/S00213-002-1002-9 |
0.334 |
|
| 2001 |
Ait-Daoud N, Johnson BA, Javors M, Roache JD, Zanca NA. Combining ondansetron and naltrexone treats biological alcoholics: corroboration of self-reported drinking by serum carbohydrate deficient transferrin, a biomarker. Alcoholism, Clinical and Experimental Research. 25: 847-9. PMID 11410720 DOI: 10.1111/J.1530-0277.2001.Tb02289.X |
0.34 |
|
| 2000 |
Johnson BA, Roache JD, Javors MA, Diclemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial Journal of the American Medical Association. 284: 963-971. PMID 10944641 DOI: 10.1001/Jama.284.8.963 |
0.327 |
|
| 2000 |
Johnson BA, Cloninger CR, Roache JD, Bordnick PS, Ruiz P. Age of onset as a discriminator between alcoholic subtypes in a treatment-seeking outpatient population American Journal On Addictions. 9: 17-27. PMID 10914290 DOI: 10.1080/10550490050172191 |
0.319 |
|
| 2000 |
Harris JT, Roache JD, Thornton JE. A role for valproate in the treatment of sedative-hypnotic withdrawal and for relapse prevention Alcohol and Alcoholism. 35: 319-323. PMID 10905994 DOI: 10.1093/Alcalc/35.4.319 |
0.311 |
|
| 2000 |
Roache JD, Grabowski J, Schmitz JM, Creson DL, Rhoades HM. Laboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatment Journal of Clinical Psychopharmacology. 20: 61-68. PMID 10653210 DOI: 10.1097/00004714-200002000-00011 |
0.432 |
|
| 1999 |
Oswald LM, Roache JD, Rhoades HM. Predictors of individual differences in alprazolam self-medication. Experimental and Clinical Psychopharmacology. 7: 379-90. PMID 10609973 DOI: 10.1037//1064-1297.7.4.379 |
0.663 |
|
| 1999 |
Johnson BA, Roache JD, Bordnick PS, Ait-Daoud N. Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: A preliminary study Psychopharmacology. 144: 295-300. PMID 10435398 DOI: 10.1007/S002130051007 |
0.353 |
|
| 1997 |
Spiga R, Macenski MJ, Meisch RA, Roache JD. Human ethanol self-administration I: The interaction between response requirement and ethanol dose Behavioural Pharmacology. 8: 91-100. PMID 9833005 DOI: 10.1097/00008877-199702000-00010 |
0.325 |
|
| 1997 |
Grabowski J, Roache JD, Schmitz JM, Rhoades H, Creson D, Korszun A. Replacement medication for cocaine dependence: Methylphenidate Journal of Clinical Psychopharmacology. 17: 485-488. PMID 9408812 DOI: 10.1097/00004714-199712000-00008 |
0.412 |
|
| 1997 |
Streufert S, Satish U, Pogash R, Gingrich D, Landis R, Roache J, Severs W. Excess coffee consumption in simulated complex work settings: detriment or facilitation of performance? The Journal of Applied Psychology. 82: 774-82. PMID 9337609 DOI: 10.1037/0021-9010.82.5.774 |
0.351 |
|
| 1997 |
Mintzer MZ, Guarino J, Kirk T, Roache JD, Griffiths RR. Ethanol and pentobarbital: comparison of behavioral and subjective effects in sedative drug abusers. Experimental and Clinical Psychopharmacology. 5: 203-15. PMID 9260068 DOI: 10.1037/1064-1297.5.3.203 |
0.377 |
|
| 1997 |
Roache JD, Stanley MA, Creson DR, Shah NN, Meisch RA. Alprazolam-reinforced medication use in outpatients with anxiety. Drug and Alcohol Dependence. 45: 143-55. PMID 9179516 DOI: 10.1016/S0376-8716(97)01354-9 |
0.401 |
|
| 1996 |
Streufert S, Satish U, Pogash R, Gingrich D, Landis JR, Lonardi L, Miller J, Severs W, Roache JD. Effects of alprazolam on complex human functioning Journal of Applied Social Psychology. 26: 1912-1930. DOI: 10.1111/J.1559-1816.1996.Tb00105.X |
0.325 |
|
| 1996 |
Roache JD, Stanley MA, Creson DL, Meisch RA, Shah NN. Diazepam reinforcement in anxious patients Experimental and Clinical Psychopharmacology. 4: 308-314. DOI: 10.1037//1064-1297.4.3.308 |
0.387 |
|
| 1995 |
Streufert S, Pogash R, Braig D, Gingrich D, Kantner A, Landis R, Lonardi L, Roache J, Severs W. Alcohol hangover and managerial effectiveness. Alcoholism, Clinical and Experimental Research. 19: 1141-6. PMID 8561282 DOI: 10.1111/J.1530-0277.1995.Tb01592.X |
0.339 |
|
| 1995 |
Roache JD, Meisch RA, Henningfield JE, Jaffe JH, Klein S, Sampson A. Reinforcing effects of triazolam in sedative abusers: Correlation of drug liking and self-administration measures Pharmacology, Biochemistry and Behavior. 50: 171-179. PMID 7740055 DOI: 10.1016/0091-3057(94)00281-M |
0.404 |
|
| 1995 |
Streufert S, Pogash R, Miller J, Gingrich D, Landis R, Lonardi L, Severs W, Roache JD. Effects of caffeine deprivation on complex human functioning. Psychopharmacology. 118: 377-84. PMID 7568623 DOI: 10.1007/Bf02245937 |
0.338 |
|
| 1994 |
Streufert S, Pogash R, Roache J, Severs W, Gingrich D, Landis R, Lonardi L, Kantner A. Alcohol and managerial performance. Journal of Studies On Alcohol. 55: 230-8. PMID 8189744 DOI: 10.15288/Jsa.1994.55.230 |
0.338 |
|
| 1993 |
Roache JD, Cherek DR, Bennett RH, Schenkler JC, Cowan KA. Differential effects of triazolam and ethanol on awareness, memory, and psychomotor performance Journal of Clinical Psychopharmacology. 13: 3-15. PMID 8486815 DOI: 10.1097/00004714-199302000-00002 |
0.399 |
|
| 1993 |
Roache JD, Spiga R, Burt DB. Triazolam and ethanol effects on human matching-to-sample performance vary as a function of pattern size and discriminability Drug and Alcohol Dependence. 32: 219-229. PMID 8348874 DOI: 10.1016/0376-8716(93)90086-6 |
0.315 |
|
| 1993 |
Cherek DR, Roache JD, Egli M, Davis C, Spiga R, Cowan K. Acute effects of marijuana smoking on aggressive, escape and point-maintained responding of male drug users Psychopharmacology. 111: 163-168. PMID 7870947 DOI: 10.1007/Bf02245518 |
0.306 |
|
| 1993 |
Streufert S, Pogash RM, Gingrich D, Kantner A, Lonardi L, Severs W, Landis R, Roache J. Alcohol and Complex Functioning1 Journal of Applied Social Psychology. 23: 847-866. DOI: 10.1111/J.1559-1816.1993.Tb01009.X |
0.356 |
|
| 1992 |
Streufert S, Pogash RM, Roache J, Gingrich D, Landis R, Severs W, Lonardi L, Kantner A. Effects of alcohol intoxication on risk taking, strategy, and error rate in visuomotor performance. The Journal of Applied Psychology. 77: 515-24. PMID 1512185 DOI: 10.1037/0021-9010.77.4.515 |
0.354 |
|
| 1991 |
Cherek DR, Spiga R, Roache JD, Cowan KA. Effects of triazolam on human aggressive, escape and point-maintained responding Pharmacology, Biochemistry and Behavior. 40: 835-839. PMID 1816570 DOI: 10.1016/0091-3057(91)90094-I |
0.333 |
|
| 1991 |
ROACHE JD. Performance and physiological measures in abuse liability evaluation British Journal of Addiction. 86: 1595-1600. PMID 1786492 DOI: 10.1111/J.1360-0443.1991.Tb01753.X |
0.336 |
|
| 1990 |
Spiga R, Cherek DR, Roache JD, Cowan KA. The effects of codeine on human aggressive responding International Clinical Psychopharmacology. 5: 195-204. PMID 2230064 DOI: 10.1097/00004850-199007000-00005 |
0.368 |
|
| 1990 |
Kirk T, Roache JD, Griffiths RR. Dose-response evaluation of the amnestic effects of triazolam and pentobarbital in normal subjects Journal of Clinical Psychopharmacology. 10: 160-167. PMID 2198294 DOI: 10.1097/00004714-199006000-00002 |
0.355 |
|
| 1990 |
Roache JD, Cherek DR, Spiga R, Bennett RH, Cowan KA, Yingling J. Benzodiazepine-induced impairment of matching-to-sample performance in humans Pharmacology, Biochemistry and Behavior. 36: 945-952. PMID 1977179 DOI: 10.1016/0091-3057(90)90104-P |
0.313 |
|
| 1990 |
Roache JD. Addiction potential of benzodiazepines and non-benzodiazepine anxiolytics Advances in Alcohol and Substance Abuse. 9: 103-128. PMID 1974120 DOI: 10.1300/J251V09N01_07 |
0.343 |
|
| 1990 |
Roache J, Griffiths R. Diazepam and triazolam self-administration in sedative abusers: concordance of subject ratings, performance and drug self-administration Journal of Clinical Psychopharmacology. 10: 137-138. DOI: 10.1097/00004714-199004000-00015 |
0.343 |
|
| 1989 |
Roache JD, Griffiths RR. Diazepam and triazolam self-administration in sedative abusers: concordance of subject ratings, performance and drug self-administration Psychopharmacology. 99: 309-315. PMID 2594898 DOI: 10.1007/Bf00445549 |
0.391 |
|
| 1987 |
Roache JD, Griffiths RR. Interactions of diazepam and caffeine: Behavioral and subjective dose effects in humans Pharmacology, Biochemistry and Behavior. 26: 801-812. PMID 3602037 DOI: 10.1016/0091-3057(87)90614-9 |
0.401 |
|
| 1986 |
Roache JD, Griffiths RR. Repeated administration of diazepam and triazolam to subjects with histories of drug abuse Drug and Alcohol Dependence. 17: 15-29. PMID 3720528 DOI: 10.1016/0376-8716(86)90032-3 |
0.397 |
|
| 1986 |
Roache JD, Zabik JE. Effects of benzodiazepines on taste aversions in a two-bottle choice paradigm Pharmacology, Biochemistry and Behavior. 25: 431-437. PMID 3020595 DOI: 10.1016/0091-3057(86)90020-1 |
0.301 |
|
| 1986 |
Cone EJ, Johnson RE, Moore JD, Roache JD. Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects Pharmacology, Biochemistry and Behavior. 24: 1749-1754. PMID 3016764 DOI: 10.1016/0091-3057(86)90515-0 |
0.307 |
|
| 1985 |
Griffiths RR, Lamb RJ, Ator NA, Roache JD, Brady JV. Relative abuse liability of triazolam: experimental assessment in animals and humans. Neuroscience and Biobehavioral Reviews. 9: 133-51. PMID 2858078 DOI: 10.1016/0149-7634(85)90039-9 |
0.394 |
|
| 1984 |
Griffiths RR, McLeod DR, Bigelow GE, Liebson IA, Roache JD, Nowowieski P. Comparison of diazepam and oxazepam: Preference, liking and extent of abuse Journal of Pharmacology and Experimental Therapeutics. 229: 501-508. PMID 6716272 |
0.312 |
|
| 1984 |
Griffiths RR, McLeod DR, Bigelow GE, Liebson IA, Roache JD. Relative abuse liability of diazepam and oxazepam: Behavioral and subjective dose effects Psychopharmacology. 84: 147-154. PMID 6438672 DOI: 10.1007/Bf00427437 |
0.422 |
|
| Show low-probability matches. |